Profile picture of Dr. Pascale A. Guitera

Dermatologist

Australian Flag

Pascale A. Guitera

Icon representing available degree

PhD; MD; FACD

Icon that representing available experience

23 Years Overall Experience

Icon representing available city of this doctor

Camperdown

Connect with Pascale A. Guitera

Quick Appointment for Pascale A. Guitera

No OPD information available

Services Offered by Pascale A. Guitera

  • Melanoma

  • Melasma

  • Basal Cell Skin Cancer

  • Extramammary Paget Disease

  • Neuroendocrine Tumor

  • Actinic Keratosis

  • Cheilitis Glandularis

  • Anal Cancer

  • Congenital Aplastic Anemia

  • Cutaneous T-Cell Lymphoma (CTCL)

  • Fanconi Anemia

  • Giant Congenital Melanocytic Nevus

  • Lichen Planus

  • Mycosis Fungoides

  • Nevoid Basal Cell Carcinoma Syndrome

  • Pigmented Purpuric Dermatosis

  • Porphyria

  • Squamous Cell Skin Carcinoma

  • Sunburn

  • T-Cell Lymphoma

About Of Pascale A. Guitera

Pascale A. Guitera is a female doctor who helps patients with skin problems like melanoma, sunburn, and other skin cancers. She also treats conditions like lichen planus, porphyria, and T-cell lymphoma.

Dr. Guitera uses special skills and treatments to help her patients. She is good at using a tool called reflectance confocal microscopy to check skin problems before surgery. This helps her make better decisions about treatment.

Patients like Dr. Guitera because she talks to them in a friendly and clear way. She listens to their concerns and explains things in a simple manner. This makes patients feel comfortable and trust her expertise.

Dr. Guitera stays updated with the latest medical knowledge by reading research papers and attending conferences. This helps her provide the best care for her patients and stay ahead in her field.

She works well with other doctors and professionals in the medical field. She shares her knowledge and collaborates with colleagues to improve patient care. This teamwork approach benefits patients and ensures they receive the best possible treatment.

Dr. Guitera's work has positively impacted many patients' lives. Her research on reflectance confocal microscopy has improved the management of skin conditions like lentigo maligna and lentigo maligna melanoma. Her clinical trial on using imiquimod versus radiotherapy for lentigo maligna has also helped advance treatment options for patients.

Overall, Dr. Guitera is a dedicated and skilled doctor who uses her expertise to help patients with skin problems. Her commitment to staying updated with the latest research and working collaboratively with colleagues shows her dedication to providing the best care for her patients.

Education of Pascale A. Guitera

  • MD — Doctor of Medicine; Paris VII University, France; 2002

  • Dermatology Fellowship / Training; Hospital Saint-Louis, Paris, France

  • FACD - Australasian Dermatology Fellowship; Fellowship of Australasian College of Dermatologists; 2008

  • PhD — Non invasive imaging / skin tumour diagnostics; Curie Institute (Paris) & Royal Prince Alfred Hospital (Sydney); 2010

Memberships of Pascale A. Guitera

  • Fellow of the Australasian College of Dermatologists (FACD)

  • Faculty Member, Melanoma Institute Australia

Publications by Pascale A. Guitera

Reflectance confocal microscopy: Presurgical margin assessment improves lentigo maligna and lentigo maligna melanoma management.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Year: January 15, 2025
Authors: Cristian Navarrete Dechent, Caterina Longo, Konstantinos Liopyris, Marco Ardigo, Verena Ahlgrimm Siess, Phillipe Bahadoran, Cristina Carrera, Juliana Tavoloni Braga, Chih-shan Chen, Lilia Correa, Nathalie De Carvahlo, John Durkin, Francesca Farnetani, Jane Grant Kels, Melissa Gill, Salvador Gonzalez, Daniela Hartmann, Rainer Hoffman Wellenhof, Albert Huho, Joanna Ludzik, Josep Malvehy, Ashfaq Marghoob, Elvira Moscarella, Margaret Oliviero, Susana Puig, Harold Rabinovitz, Babar Rao, Gisele Rezze, Anthony Rossi, Gene Rubinstein, Cristel Ruini, Elke Sattler, H Soyer, Rodrigo Schwartz, Steven Thng, Martina Ulrich, Alexander Witkowski, Stephen Dusza, Pascale Guitera, Giovanni Pellacani, Alon Scope, Manu Jain

Description:Background: There is lack of uniformity in reflectance confocal microscopy (RCM) terminology. Objective: To establish expert consensus on a standardized set of RCM terms that describe non-melanocytic lesions (NMLs). Methods: We invited RCM experts to participate in a Delphi-consensus study. Fifty-nine RCM descriptors were extracted from a previous systematic review on RCM terminology for describing NML. Of these, 35 items were presented as 4 groups of synonymous terms and 24 items as single, nonsynonymous terms. For the first round, an agreement threshold was set at >70%. Participants could also propose new terms. Terms with ≤70% agreement and newly proposed terms were carried over to the next round. For subsequent rounds, agreement threshold was set at >50%. Results: The study was conducted between June 2021 and May 2023. Forty-two of 44 (95%) invited experts participated. Three iterative Delphi rounds were completed, resulting in a consensus list of 36 terms, including 32 synonymous and 4 nonsynonymous terms for describing NML. Conclusions: Only experts were included. We did not evaluate definitions of terms in the study. Conclusions: We propose a simplified list of RCM terms, vetted by RCM experts, for describing and diagnosing NML. Uniform terminology could benefit clinical practice, research, and education.

Pre- and post-treatment care for actinic keratoses: An Australian and New Zealand perspective.

Journal: Australian Journal Of General Practice
Year: August 04, 2025
Authors: John O'bryen, Solange Green, A Seine, Jeremy Hudson, Ryan De Cruz, Louise Reiche, Aaron Boyce, Philip Tong, Jim Siderov, Pascale Guitera

Description:Background: Actinic keratoses (AKs), also known as solar keratoses, are precancerous skin lesions that typically occur following long-term exposure to ultraviolet radiation. AKs can evolve into cutaneous squamous cell carcinoma (SCC) if left untreated. Treatments for AKs typically cause temporary, irritable erythematous skin barrier disruption. Objective: The objective of this article is to provide recommendations for the pre-treatment and post-treatment care for AKs in order to improve patient outcomes, particularly in the Australian and New Zealand setting. Conclusions: Many of the treatments for AKs have associated side effects that might affect skin barrier function. Post-treatment care is required to aid skin repair and to protect the skin. Patients should be instructed on how to care for the skin during the healing process using a gentle skin cleanser and a moisturiser. Routine sun protection measures all year round reduce recurrence and progression of AKs.

Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia.

Journal: The Australasian Journal Of Dermatology
Year: May 28, 2025
Authors: Liam Caffery, Monica Taylor, Lisa Abbott, Monika Janda, Pascale Guitera, Victoria Mar, Chris Arnold, Stephen Shumack, Tony Caccetta, Robert Miller, H Soyer

Description:Artificial Intelligence (AI) refers to the ability of computers to mimic human intelligence. In response to the growing interest and impact of AI, the Australasian College of Dermatologists released its first Position Statement on AI in dermatology in 2022. This Position Statement provided guidance for dermatologists on the appropriate use of AI. Since then, the AI landscape has evolved substantially, particularly with the emergence of Large Language Models (LLMs). This article explores key developments in AI driven by LLMs, including the increasing use of AI scribes, and provides updated guidance for dermatologists in Australia.

Clinical Trials by Pascale A. Guitera

A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails

Enrollment Status: Completed

Published: June 20, 2024

Intervention Type: Drug, Radiation

Study Drug: Imiquimod

Study Phase: Phase 3

A Randomised Controlled Pilot Trial of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

Enrollment Status: Completed

Published: August 01, 2023

Intervention Type: Device, Behavioral

Study Drug:

Study Phase: Not Applicable

Frequently Asked Questions About Pascale A. Guitera

What conditions does Pascale A. Guitera specialize in treating as a dermatologist?

Pascale A. Guitera specializes in treating a wide range of dermatological conditions including skin cancer, acne, eczema, psoriasis, and more.

What services does Pascale A. Guitera offer for skin cancer detection and treatment?

Pascale A. Guitera offers comprehensive skin cancer screenings, mole mapping, biopsies, and various treatment options including surgery, topical therapies, and photodynamic therapy.

How can Pascale A. Guitera help with acne management?

Pascale A. Guitera provides personalized acne treatment plans that may include topical medications, oral medications, chemical peels, and laser therapy to effectively manage and improve acne.

Does Pascale A. Guitera offer cosmetic dermatology services?

Yes, Pascale A. Guitera offers a range of cosmetic dermatology services such as Botox, dermal fillers, laser treatments for skin rejuvenation, and more to enhance skin appearance.

What should patients expect during a skin examination with Pascale A. Guitera?

During a skin examination, Pascale A. Guitera will carefully assess the skin for any abnormalities, discuss any concerns the patient may have, and recommend appropriate treatment or further evaluation if needed.

How can Pascale A. Guitera help patients with concerns about skin aging?

Pascale A. Guitera offers anti-aging treatments such as chemical peels, microneedling, and laser therapies to address concerns related to skin aging, wrinkles, and sun damage, helping patients achieve a more youthful appearance.

More Dermatologist Like Pascale A. Guitera in Camperdown

Toparrow